HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.

MLA

Tan, Ryan Shea Ying Cong, et al. “HER2 Expression, Copy Number Variation and Survival Outcomes in HER2-Low Non-Metastatic Breast Cancer: An International Multicentre Cohort Study and TCGA-METABRIC Analysis.” BMC Medicine, vol. 20, no. 1, Mar. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12916-022-02284-6.

APA

Tan, R. S. Y. C., Ong, W. S., Lee, K.-H., Lim, A. H., Park, S., Park, Y. H., Lin, C.-H., Lu, Y.-S., Ono, M., Ueno, T., Naito, Y., Onishi, T., Lim, G.-H., Tan, S.-M., Lee, H.-B., Ryu, H. S., Han, W., Tan, V. K. M., Wong, F.-Y., & Im, S.-A. (2022). HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis. BMC Medicine, 20(1), 1–15. https://doi.org/10.1186/s12916-022-02284-6

Chicago

Tan, Ryan Shea Ying Cong, Whee Sze Ong, Kyung-Hun Lee, Abner Herbert Lim, Seri Park, Yeon Hee Park, Ching-Hung Lin, et al. 2022. “HER2 Expression, Copy Number Variation and Survival Outcomes in HER2-Low Non-Metastatic Breast Cancer: An International Multicentre Cohort Study and TCGA-METABRIC Analysis.” BMC Medicine 20 (1): 1–15. doi:10.1186/s12916-022-02284-6.